The Chemokine CXCL10 as a Therapeutic Target in Animal Models of Neuroinflammatory Disease

Publisher： Bentham Science Publishers

E-ISSN： 1875-628x|3|10|683-688

ISSN： 1570-1808

Source： Letters in Drug Design & Discovery, Vol.3, Iss.10, 2006-12, pp. : 683-688

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dysregulated Chemokine Signaling in Cystic Fibrosis Lung Disease: A Potential Therapeutic Target

By  

Current Drug Targets, Vol. 17, Iss. 13, 2016-09 ,pp. : 1535-1544

Bentham Science Publishers

Access to resources Recommend Favorite

Cannabinoids as Therapeutic Agents for Ablating Neuroinflammatory Disease

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 8, Iss. 3, 2008-09 ,pp. : 159-172

Bentham Science Publishers

Access to resources Recommend Favorite

The Neuroinflammatory Response in Plaques and Amyloid Angiopathy in Alzheimer's Disease: Therapeutic Implications

By  

Current Drug Targets-CNS & Neurological Disorders, Vol. 4, Iss. 3, 2005-06 ,pp. : 223-233

Bentham Science Publishers

Access to resources Recommend Favorite

CXCL8 as a Potential Therapeutic Target for HIV-Associated Neurocognitive Disorders

By  

Current Drug Targets, Vol. 17, Iss. 1, 2016-01 ,pp. : 111-121

Bentham Science Publishers

Access to resources Recommend Favorite

The Chemokine Receptor CXCR4 as a Therapeutic Target for Several Diseases

By  

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 9, 2006-09 ,pp. : 989-995

Bentham Science Publishers

Access to resources Recommend Favorite